Holen Sie sich die Stockscreener-App
308.86
0.87%
2.66
Handel nachbörslich:
306.00
-2.86
-0.93%
Schlusskurs vom Vortag:
$306.20
Offen:
$306.74
24-Stunden-Volumen:
291.31K
Relative Volume:
0.69
Marktkapitalisierung:
$11.95B
Einnahmen:
$3.26B
Nettoeinkommen (Verlust:
$503.61M
KGV:
28.09
EPS:
10.9949
Netto-Cashflow:
$718.54M
1W Leistung:
+4.17%
1M Leistung:
-4.74%
6M Leistung:
+36.60%
1J Leistung:
-0.80%
1-Tages-Spanne:
$303.99
$312.19
1-Wochen-Bereich:
$292.97
$320.00
52-Wochen-Spanne:
$148.63
$364.42
Evercore Inc Stock (EVR) Company Profile
Firmenname
Evercore Inc
Sektor
Branche
Telefon
212-857-3100
Adresse
55 EAST 52ND STREET, NEW YORK, NY
Vergleichen Sie EVR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVR
Evercore Inc
|
308.86 | 11.84B | 3.26B | 503.61M | 718.54M | 10.99 |
|
MS
Morgan Stanley
|
162.83 | 251.38B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
790.71 | 232.15B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
90.52 | 160.83B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
114.97 | 96.48B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
348.19 | 27.53B | 14.13B | 1.12B | 45.45M | 14.62 |
Evercore Inc Stock (EVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-09 | Eingeleitet | Deutsche Bank | Buy |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-06-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-04-08 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-20 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-11 | Hochstufung | Goldman | Neutral → Buy |
| 2024-01-29 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2024-01-09 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-22 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-12 | Hochstufung | UBS | Sell → Buy |
| 2023-01-11 | Hochstufung | Goldman | Neutral → Buy |
| 2022-10-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-09-23 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-06 | Herabstufung | Goldman | Buy → Neutral |
| 2021-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-09 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-03-19 | Bestätigt | Goldman | Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-12-16 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-12-01 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-02 | Hochstufung | UBS | Neutral → Buy |
| 2020-08-05 | Hochstufung | Goldman | Neutral → Buy |
| 2020-07-09 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-06 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-08-14 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-05-23 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-07 | Herabstufung | Goldman | Neutral → Sell |
| 2018-11-06 | Eingeleitet | Goldman | Neutral |
| 2018-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2017-05-23 | Herabstufung | Goldman | Buy → Neutral |
| 2017-03-27 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2017-02-16 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-02-13 | Herabstufung | Instinet | Buy → Neutral |
| 2016-12-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2016-11-21 | Fortgesetzt | Credit Suisse | Outperform |
Alle ansehen
Evercore Inc Aktie (EVR) Neueste Nachrichten
Ultragenyx (NASDAQ: RARE) to join Citi, Evercore healthcare investor conferences - Stock Titan
Sana Biotechnology, Inc. to Webcast Presentations at December Investor Conferences - Quiver Quantitative
Sana Biotechnology (NASDAQ: SANA) to Present at 2025 Citi and Evercore Conferences - Stock Titan
AMGEN TO PRESENT AT THE 8TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE - MarketScreener
Amgen (NASDAQ: AMGN) to webcast Evercore ISI HealthCONx presentation Dec. 3 - Stock Titan
AutoNation (AN) Analyst Rating: Evercore ISI Group Raises Price Target to $300 | AN Stock News - GuruFocus
APTV: Evercore ISI Group Raises Price Target to $100 | APTV Stoc - GuruFocus
GM Stock: Evercore ISI Group Raises Price Target to $74.00 | GM - GuruFocus
Ford Motor (F): Evercore ISI Group Raises Price Target to $12.00 | F Stock News - GuruFocus
Lear (LEA): Evercore ISI Group Raises Price Target to $120.00 | LEA Stock News - GuruFocus
Evercore ISI Group Raises BorgWarner (BWA) Price Target, Maintai - GuruFocus
BJ's Wholesale Club (BJ) Analyst Rating Updated by Evercore | BJ Stock News - GuruFocus
Evercore ISI Group Maintains Magna International (MGA) Rating, R - GuruFocus
Evercore ISI Raises Price Target for Autoliv (ALV) to $150 | ALV Stock News - GuruFocus
Ford Motor (NYSE:F) Price Target Raised to $12.00 at Evercore ISI - MarketBeat
Beam Therapeutics (BEAM) Receives New 'Outperform' Rating from E - GuruFocus
Evercore ISI Remains Bullish on Air Products and Chemicals (APD) Following Q4 2025 Results - Insider Monkey
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - MarketScreener
QuantumScape (QS) Receives Downgrade from Evercore ISI Group Tod - GuruFocus
Evercore ISI Adjusts Price Target on Aptiv to $100 From $95, Maintains Outperform Rating - MarketScreener
Evercore ISI Adjusts Price Target on Align Technology to $220 From $170, Maintains Outperform Rating - MarketScreener
Viatris (Nasdaq: VTRS) schedules Dec. 2–3 fireside chats at Piper Sandler and Evercore - Stock Titan
Evercore ISI Downgrades QuantumScape to In Line From Outperform, Adjusts Price Target to $12 From $8 - MarketScreener
Vera Therapeutics (Nasdaq: VERA) joins Evercore and Citi 2025 healthcare investor events - Stock Titan
Dianthus Therapeutics To Participate in the 8th Annual Evercore Healthcare Conference - The Manila Times
Sionna Therapeutics (Nasdaq: SION) to Present at Evercore and Citi Investor Events - Stock Titan
Evercore ISI raises BJ’s Wholesale stock price target to $95 on member focus - Investing.com India
Evercore ISI lowers Post Holdings stock price target on cereal concerns - Investing.com India
IDEAYA Biosciences (NASDAQ: IDYA) at 2025 Citi and Evercore investor events - Stock Titan
Why You Might Be Interested In Evercore Inc. (NYSE:EVR) For Its Upcoming Dividend - Yahoo Finance
NVDA: Nvidia Hits New Street-High Target -- Stock Could Jump 95% - Yahoo Finance
Gap price target raised to $28 from $25 at Evercore ISI - Yahoo Finance
Nvidia to skyrocket 95%? Evercore drops a target that has Wall Street buzzinghere's the reason it gave - The Economic Times
Ryman (RHP) Receives a Buy from Evercore ISI - The Globe and Mail
Pebblebrook Hotel (PEB) Gets a Hold from Evercore ISI - The Globe and Mail
Lazard, Evercore, and BGC Shares Are Soaring, What You Need To Know - The Globe and Mail
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December - Koreabizwire
Evercore ISI Group Maintains Gap (GAP) Outperform Recommendation - Nasdaq
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Wix.com (NASDAQ:WIX) Price Target Cut to $160.00 by Analysts at Evercore ISI - MarketBeat
Evercore ISI Forecasts Strong Price Appreciation for Lowe's Companies (NYSE:LOW) Stock - MarketBeat
Nvidia Stock Could Jump 95% After Evercore Sets New Street-High Target - TradingView
Ross Stores (ROST) Analyst Rating Update: Evercore ISI Group Rai - GuruFocus
Evercore ISI Adjusts Price Target on Walmart to $115 From $111, Maintains Outperform Rating - MarketScreener
Why institutional investors increase stakes in Evercore Inc. (QGJ) stock - newser.com
Oric Pharmaceuticals (NASDAQ:ORIC) Coverage Initiated at Evercore ISI - MarketBeat
Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference - Yahoo Finance Singapore
Adlai Nortye (NASDAQ: ANL) to present at Evercore and Oppenheimer healthcare conferences - Stock Titan
How Evercore Inc. stock reacts to Fed rate cutsJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - newser.com
Ross Stores stock price target raised to $195 by Evercore ISI after strong Q3 - Investing.com India
Finanzdaten der Evercore Inc-Aktie (EVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
14.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):